by Gary Finnegan – World Health Matters (Australia) – Click here for more information Melbourne researchers are using Australia’s fasted supercomputer to simulate the motion of the complete… read more.
by Gary Finnegan – World Health Matters (Belgium) – Providing energy-dense food supplements to malnourished children in developing countries has limited effect on the weight of malnourished children,… read more.
by Gary Finnegan – World Health Matters (Canada) – Influenza vaccination rates vary widely in Canada depending on ethnicity, according to a new study in the Canadian Medical… read more.
by Gary Finnegan – World Health Matters (Sweden) – Breast cancer screening has limited or no impact on breast cancer mortality among women aged 40-69, according to a… read more.
by Gary Finnegan – World Health Matters (China) – Child diabetes levels in China are higher than those in the US, according to a startling new study based… read more.
by Gary Finnegan – World Health Matters (Germany) – An interdisciplinary care model for breast cancer management has grown in popularity in recent years and evidence suggests the… read more.
by Gary Finnegan – World Health Matters (South Korea) – Stem cells could be used to restore neuron function to parts of the brain damaged by Huntington’s disease… read more.
by Gary Finnegan – World Health Matters (Holland) – Higher levels of public reimbursement for fertility treatment can positively influence national birth rates, according to a study by… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The European Medicines Agency has updated its guidelines for pharmaceutical companies developing medicines for Parkinson’s disease.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The European Medicines Agency (EMA) has given its backing to the use of a Hexaxim outside the… read more.
Emerging uses of EMA Approved Drugs – by Gary Finnegan – Several new medicines have been approved by the European Medicines Agency after recent meetings of its Committee… read more.
Emerging uses of EMA Approved Drugs – by Gary Finnegan – The EMA has launched a public consultation on the classification of advanced therapies.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
